RVL Pharmaceuticals plc·4

Aug 9, 5:18 PM ET

Avista Capital Partners III GP, L.P. 4

4 · RVL Pharmaceuticals plc · Filed Aug 9, 2022

Insider Transaction Report

Form 4
Period: 2022-08-08
Transactions
  • Purchase

    Ordinary Shares

    2022-08-08$1.55/sh+8,000,000$12,400,00023,730,864 total
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    1,032,995
Footnotes (2)
  • [F1]Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F2]Represents shares of the Issuer held by Orbit Co-Invest III LLC. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Documents

1 file
  • 4
    tm2222999-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT